⌘K

Login Start Free

Home/Filings/4/0001179110-15-014694

4//SEC Filing

Ocata Therapeutics, Inc. 4

Accession 0001179110-15-014694

CIK 0001140098operating

View on SEC.gov Company Profile

Filed

Nov 9, 7:00 PM ET

Accepted

Nov 10, 4:04 PM ET

Size

7.6 KB

Accession

0001179110-15-014694

Insider Transaction Report

Form 4

Period: 2015-11-10

Ocata Therapeutics, Inc.OCAT

Chief Scientific Officer

Transactions

Sale
Common Stock
2015-11-10$8.36/sh−10,000$83,600→ 206,509 total
Sale
Common Stock
2015-11-10$8.36/sh−10,000$83,600→ 196,509 total
Sale
Common Stock
2015-11-10$8.25/sh−15,000$123,750→ 216,509 total

Footnotes (1)

[F1]Shares sold pursuant to a 10b5-1 Plan.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

Ocata Therapeutics, Inc.

CIK 0001140098

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001140098

Filing Metadata

Form type: 4
Filed: Nov 9, 7:00 PM ET
Accepted: Nov 10, 4:04 PM ET
Size: 7.6 KB

View on SEC.gov